目前对于原发性肝癌的治疗仍以手术为主,而中晚期患者,往往已失去手术机会,此时肝动脉栓塞化疗(TACE)是治疗丧失手术机会的肝癌的有效手段之一[1]。目的是造成肿瘤缺血性和化学性坏死,消灭肿瘤血管支配区域内的癌细胞[2],以控制病灶,延长生存期。但有些患者行TACE治疗不良反应 At present, the treatment of primary liver cancer is still based on surgery, and patients in the middle and late stage often have lost surgical opportunities. Transcatheter arterial chemoembolization (TACE) is one of the effective means to treat inoperable liver cancer [1]. The purpose is to cause ischemic and chemical necrosis of the tumor and eliminate cancer cells within the tumor’s innervation area [2] to control the lesion and prolong its survival. However, some patients underwent TACE for adverse reactions